Sagimet Biosciences Inc. SGMT
- denifanstat — Metabolic Dysfunction-Associated Steatohepatitis Phase 2
- denifanstat — Acne Vulgaris NDA Submitted
- TVB-3567 — Acne Vulgaris Phase 1
FASN (1 companies · 3 programs)
Companies with an active program directed at FASN.